510(k) for Medtox Scientific:
This article was originally published in Clinica
The Profile-II system developed by Medtox Scientific has been approved by the FDA. The system is an on-site drugs-of-abuse test kit which is able to detect the five most common drugs of abuse - cannabanoids, cocaine, opiates, amphetamines and PCP - in one step using a single sample. The company expects to begin shipping the product next month.
You may also be interested in...
Sandoz Canada has become the first manufacturer to launch generic versions of posaconazole and silodosin in Canada. The company launched the generic version of Allergan’s Rapaflo (silodosin) after a Canadian court ruled that Sandoz did not infringe a key formulation patent.
US healthcare insurance provider Health Net failed to respect Amarin’s patent rights in the way it distributed Hikma’s generic version of Vascepa (icosapent ethyl), the originator contends in an expanded induced infringement suit.
Netherlands' Authority for Consumers and Markets has reprimanded a dietary supplements player for purchasing fake followers and likes on social media to exaggerate the popularity of its products. It is the first case of its kind in the country.